PhaseBio Pharmaceuticals, Inc.

PHAS · NASDAQ
Analyze with AI
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Assets
Cash & Equivalents$41,800$28,122$74,025$61,031
Short-Term Investments$0$0$0$0
Receivables$0$0$1,233$233
Inventory$0$0$0$0
Other Curr. Assets$6,984$12,027$3,565$1,364
Total Curr. Assets$48,784$40,149$78,823$62,628
Property Plant & Equip (Net)$11,699$10,151$3,639$355
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$57$57$32$43
Total NC Assets$11,756$10,208$3,671$398
Other Assets$0$0$0$0
Total Assets$60,540$50,357$82,494$63,026
Liabilities
Payables$12,570$3,674$2,921$1,806
Short-Term Debt$5,413$5,355$2,378$0
Tax Payable$0$0$0$0
Deferred Revenue$1,547$0$0$0
Other Curr. Liab.$8,353$5,931$3,180$2,771
Total Curr. Liab.$27,883$14,960$8,479$4,577
LT Debt$2,432$6,773$12,326$7,500
Deferred Rev, NC$7,622$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$115,637$53,826$1,711$22
Total NC Liab.$125,691$60,599$14,037$7,522
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$153,574$75,559$22,516$12,099
Equity
Pref Stock$0$0$0$63,026
Common Stock$48$29$29$25
Retained Earnings-$391,794-$260,723-$162,158-$122,911
AOCI$0$0-$1,959-$1,785
Other Equity$298,712$235,492$224,066$112,572
Total Equity-$93,034-$25,202$59,978$50,927
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$60,540$50,357$82,494$63,026
Net Debt-$33,955-$15,994-$59,321-$53,531
PhaseBio Pharmaceuticals, Inc. (PHAS) Financial Statements & Key Stats | AlphaPilot